Search research articles
Contact Us
Filters
Showing results (71-80 of 206) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer
Pierre Laurent-Puig, Marie-Lise Grisoni, Volker Heinemann, et al.
Cancer Science
|
March 14, 2013
Early tumor shrinkage in metastatic colorectal cancer: retrospective analysis from an irinotecan-based randomized first-line trial
Clemens Giessen, Ruediger P Laubender, Ludwig Fischer von Weikersthal, et al.
Cureus
|
June 11, 2016
CyberKnife Radiosurgery - Value as an Adjunct to Surgical Treatment of HCC?
Markus Schoenberg, Andrey Khandoga, Sebastian Stintzing, et al.
Journal of Clinical Medicine
|
June 10, 2023
Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade
Christopher C M Neumann, François Schneider, Georg Hilfenhaus, et al.
Langenbeck'S Archives of Surgery
|
August 14, 2017
Synchronous colorectal liver metastases: focus on the elderly : An Effectiveness Study from Routine Care
Markus Albertsmeier, Andrea Engel, Markus O Guba, et al.
Cancers
|
October 29, 2020
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, et al.
The Journal of Pathology
|
December 17, 2014
Under-expression of α8 integrin aggravates experimental atherosclerosis
Carlos Menendez-Castro, Nada Cordasic, Daniel Neureiter, et al.
International Journal of Cancer
|
May 31, 2012
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group
Sebastian Stintzing, Christine Kapaun, Rüdiger Paul Laubender, et al.
Cancers
|
July 27, 2024
Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy-The CONKO 021-ChemTox Trial
Tobias Bleumer, Janine Abel, Wolfgang Böhmerle, et al.
Clinical Colorectal Cancer
|
June 16, 2022
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial
Hiroyuki Arai, Joshua Millstein, Yan Yang, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 206) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer
Pierre Laurent-Puig, Marie-Lise Grisoni, Volker Heinemann, et al.
Cancer Science
|
March 14, 2013
Early tumor shrinkage in metastatic colorectal cancer: retrospective analysis from an irinotecan-based randomized first-line trial
Clemens Giessen, Ruediger P Laubender, Ludwig Fischer von Weikersthal, et al.
Cureus
|
June 11, 2016
CyberKnife Radiosurgery - Value as an Adjunct to Surgical Treatment of HCC?
Markus Schoenberg, Andrey Khandoga, Sebastian Stintzing, et al.
Journal of Clinical Medicine
|
June 10, 2023
Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade
Christopher C M Neumann, François Schneider, Georg Hilfenhaus, et al.
Langenbeck'S Archives of Surgery
|
August 14, 2017
Synchronous colorectal liver metastases: focus on the elderly : An Effectiveness Study from Routine Care
Markus Albertsmeier, Andrea Engel, Markus O Guba, et al.
Cancers
|
October 29, 2020
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, et al.
The Journal of Pathology
|
December 17, 2014
Under-expression of α8 integrin aggravates experimental atherosclerosis
Carlos Menendez-Castro, Nada Cordasic, Daniel Neureiter, et al.
International Journal of Cancer
|
May 31, 2012
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group
Sebastian Stintzing, Christine Kapaun, Rüdiger Paul Laubender, et al.
Cancers
|
July 27, 2024
Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy-The CONKO 021-ChemTox Trial
Tobias Bleumer, Janine Abel, Wolfgang Böhmerle, et al.
Clinical Colorectal Cancer
|
June 16, 2022
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial
Hiroyuki Arai, Joshua Millstein, Yan Yang, et al.
Page
of 21